Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

Thrombosis Research

Volumn 111, Issue 4-5, 2003, Pages 251-257

  Klinkhardt, Ute ^a   Kuczka, Karina ^a   Harder, Sebastian ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

AR C 69331 MX; Cariporide; NHE 1; Platelet leukocyte aggregates

Indexed keywords

ADENOSINE DIPHOSPHATE; AR C 69331; AR C 69331 MX; CARIPORIDE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; MARKER; PADGEM PROTEIN; PROPIONIC ACID; PROTEIN INHIBITOR; PURINE P2Y12 RECEPTOR; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CELL STIMULATION; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRANULATION; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL MODEL; FLOW CYTOMETRY; HUMAN; INCUBATION TIME; LEUKOCYTE AGGREGATION; MONOCYTE; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION;

EID: 0346433811     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.015     Document Type: Article

References (35)

1. Hamburger S.A., McEver R.P. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 75:1990;550-554.
2. Graff J., Klinkhardt U., Schini-Kerth V.B., Harder S., Franz N., Bassus S.et al. Close relationship between the platelet activation marker CD62p and the granular release of platelet-derived growth factor. J. Pharmacol. Exp. Ther. 300:2000;952-957.
3. Rupprecht H.J., vom Dahl J., Terres W., Seyfarth K.M., Richardt G., Schultheibeta H.P.et al. Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation. 27:2000;2902-2908.
4. Stromer H., de Groot M.C., Horn M., Faul C., Leupold A., Morgan J.P.et al. Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Circulation. 101:1998;2749-2755.
5. Siffert W. Regulation of platelet function by sodium-hydrogen exchange. Cardiovasc. Res. 29:1995;160-166.
6. Rosskopf D. Sodium-hydrogen exchange and platelet function. J. Thromb. Thrombolysis. 8:1999;15-24.
7. + exchanger for the generation of procoagulant activity by porcine blood platelets. Platelets. 12:2001;436-442.
8. Rosskopf D., Morgenstern E., Scholz W., Osswald U., Siffert W. Rapid determination of the elevated Na(+)-H+ exchange in platelets of patients with essential hypertension using an optical swelling assay. J. Hypertens. 9:1991;231-238.
9. Rinder C.S., Student L.A., Bonan J.L., Rinder H.M., Smith B.R. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood. 82:1993;505-512.
10. Zeng S., Yi F.X., Guo Z.G. Platelet activating factor-induced P-selectin expression in platelets and its related signal transduction. Zhōngguó Yàolǐ Xuébào. 20:1999;948-950.
11. Theroux P., Chaitman B.R., Danchin N., Erhardt L., Meinertz T., Schroeder J.S.et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation. 102:2000;3032-3038.
12. Rupprecht H.J., Darius H., Borkowski U., Voigtlander T., Nowak B., Genth S.et al. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation. 97:1998;1046-1052.
13. Chronos N.A., Wilson D.J., Janes S.L., Hutton R.A., Buller N.P., Goodall A.H. Aspirin does not affect the flow cytometric detection of fibrinogen to, or release of alpha granules or lysosomes from human platelets. Clin. Sci. (Lond.). 87:1994;574-580.
14. Klinkhardt U., Graff J., Harder S. Clopidogrel, but not abciximab reduces platelet-leukocyte conjugates and P-selectin expression in a human ex vivo-in vitro model. Clin. Pharmacol. Ther. 71:2002;176-185.
15. Klinkhardt U., Bauersachs R., Adams J., Graff J., Lindhoff-Last E., Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin. Pharmacol. Ther. 73:2003;232-241.
16. Storey R.F., Judge H.M., Wilcox R.G., Heptinstall S. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thromb. Haemost. 88:2002;488-494.
17. Schmitz G., Rothe G., Ruf A., Barlage S., Tschope D., Clemetson K.J. Consensus protocol for the flow cytometric characterization of platelet function. Thromb. Haemost. 97:1998;885-896.
18. Tarnok A., Mahnke A., Müller M., Zotz R.J. Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregation. Cytometry. 38:1999;30-39.
19. + exchange in platelets. Thromb. Haemost. 58:1987;971-977.
20. Storey R.F., Sanderson H.M., White A.E., May J.A., Cameron K.E., Heptinstall S. The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br. J. Haematol. 110:2000;925-934.
21. Weber W., Harnisch L., Jessel A. GUARDIAN trial investigators. Lessons learned from a phase III population pharmacokinetic study of cariporide in coronary artery bypass graft surgery. Clin. Pharmacol. Ther. 71:2002;457-467.
22. Storey R.F., Oldroyd K.G., Wilcox R.G. Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thromb. Haemost. 85:2001;401-407.
23. Zeymer U., Suryapranata H., Monassier J.P., Opolski G., Davies J., Rasmanis G.et al. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial. J. Am. Coll. Cardiol. 38:2001;1644-1650.
24. Bhatt D.L., Topol E.J. Scientific and therapeutic advances in antiplatelet therapy. Nat. Rev., Drug Discov. 2:2003;15-28.
25. 2+ exchanger in inside-out signaling through the platelet integrin IIbbeta3. Blood. 92:1998;3710-3720.
26. Redlin M., Werner J., Habazettl H., Griethe W., Kuppe H., Pries A.R. Cariporide (HOE 642) attenuates leukocyte activation in ischemia and reperfusion. Anesth. Analg. 93:2001;1472-1479.
27. Sheikh S., Nash G.B. Continuous activation and deactivation of integrin CD11b/CD18 during de novo expression enables rolling neutrophils to immobilize platelets. Blood. 87:1996;5040-5050.
28. Neumann F.J., Zohlnhofer D., Fakhoury L., Ott I., Gawaz M., Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J. Am. Coll. Cardiol. 34:1999;1420-1426.
29. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., Smith B.R. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 78:1991;1760-1769.
30. Evangelista V.E., Manarini S., Rotondo S. Platelet/polymorph-nuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the β2-integrin CD11b/CD18. Blood. 88:1996;146-157.
31. Ott I., Neumann F.J., Gawaz M., Schmitt M., Schomig A. Increased eutrophil-platelet adhesion in patients with unstable angina. Circulation. 94:1996;1239-1246.
32. Furman M.I., Benoit S.E., Barnard M.R., Valeri C.R., Borbone M.L., Becker R.C. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J. Am. Coll. Cardiol. 31:1998;352-358.
33. Trumel C., Payrastre B., Plantavid M., Hechler B., Viala C., Presek P. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood. 94:1999;4156-4165.
34. Gachet C. ADP receptors of platelets and their inhibition. Thromb. Haemost. 86:2001;222-232.
35. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med. 345:2001;494-502.